CEACAM5 and colorectal carcinoma: Preoperative CEA levels have been reported to be positive in only 40–60% of patients at the initial diagnosis, and the usefulness of CEA monitoring for reducing CRC mortality in postoperative patients or selecting those patients with stage II tumors who would benefit from adjuvant chemotherapy is controversial [8,9].